Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0941755/Vitamin-D-Deficiency-Disorders-Global-Clinical-Trials-Review-H2-2013.html
NEW YORK, Aug. 22, 2013 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:
$2,500!
Summary
GlobalData's clinical trial report, "Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2013" provides data on the Vitamin D Deficiency Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vitamin D Deficiency Disorders. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vitamin D Deficiency Disorders. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Vitamin D Deficiency Disorders 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Vitamin D Deficiency Disorders 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Vitamin D Deficiency Disorders Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Merck & Co., Inc. 33
Clinical Trial Overview of Merck & Co., Inc. 33
Cytochroma Inc. 34
Clinical Trial Overview of Cytochroma Inc. 34
Kyowa Hakko Kirin Pharma, Inc. 35
Clinical Trial Overview of Kyowa Hakko Kirin Pharma, Inc. 35
Pharma Patent Kft. 36
Clinical Trial Overview of Pharma Patent Kft. 36
Clalit Health Services 37
Clinical Trial Overview of Clalit Health Services 37
S:t Eriks Ogonsjukhus AB 38
Clinical Trial Overview of S:t Eriks Ogonsjukhus AB 38
Laboratoires S.M.B. 39
Clinical Trial Overview of Laboratoires S.M.B. 39
DSM Nutritional Products AG 40
Clinical Trial Overview of DSM Nutritional Products AG 40
Abbott Laboratories 41
Clinical Trial Overview of Abbott Laboratories 41
Zeria Pharmaceutical Co Ltd 42
Clinical Trial Overview of Zeria Pharmaceutical Co Ltd 42
Teva Pharmaceutical Industries Limited 43
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 43
Takeda Pharmaceutical Company Limited 44
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 44
Clinical Trial Overview of Top Institutes / Government 45
University of Wisconsin Madison 45
Clinical Trial Overview of University of Wisconsin Madison 45
Creighton University 46
Clinical Trial Overview of Creighton University 46
The Medical University of Graz 47
Clinical Trial Overview of The Medical University of Graz 47
Massachusetts General Hospital 48
Clinical Trial Overview of Massachusetts General Hospital 48
University of Alabama at Birmingham 49
Clinical Trial Overview of University of Alabama at Birmingham 49
Tufts University 50
Clinical Trial Overview of Tufts University 50
Rambam Health Care Campus 51
Clinical Trial Overview of Rambam Health Care Campus 51
Aarhus University 52
Clinical Trial Overview of Aarhus University 52
Winthrop-University Hospital 53
Clinical Trial Overview of Winthrop-University Hospital 53
Boston Medical Center 54
Clinical Trial Overview of Boston Medical Center 54
Medical University of South Carolina 55
Clinical Trial Overview of Medical University of South Carolina 55
Martin-Luther-Universitat Halle-Wittenberg 56
Clinical Trial Overview of Martin-Luther-Universitat Halle-Wittenberg 56
Mayo Clinic 57
Clinical Trial Overview of Mayo Clinic 57
McGill University 58
Clinical Trial Overview of McGill University 58
U.S. Department of Veterans Affairs 59
Clinical Trial Overview of U.S. Department of Veterans Affairs 59
University of Massachusetts 60
Clinical Trial Overview of University of Massachusetts 60
University of California, Los Angeles 61
Clinical Trial Overview of University of California, Los Angeles 61
Columbia University 62
Clinical Trial Overview of Columbia University 62
University of Toronto 63
Clinical Trial Overview of University of Toronto 63
University of Nebraska 64
Clinical Trial Overview of University of Nebraska 64
Five Key Clinical Profiles 65
Appendix 85
Abbreviations 85
Definitions 85
Research Methodology 86
Secondary Research 86
About GlobalData 87
Contact Us 87
Disclaimer 87
Source 88
List of Tables
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 15
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, BRIC Countries, 2013* 16
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, G7 Countries, 2013* 17
- Vitamin D Deficiency Disorders Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, E7 Countries, 2013* 19
- Vitamin D Deficiency Disorders Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 33
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytochroma Inc., 2013* 34
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyowa Hakko Kirin Pharma, Inc., 2013* 35
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharma Patent Kft., 2013* 36
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Clalit Health Services, 2013* 37
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by S:t Eriks Ogonsjukhus AB, 2013* 38
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires S.M.B., 2013* 39
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by DSM Nutritional Products AG, 2013* 40
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2013* 41
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeria Pharmaceutical Co Ltd, 2013* 42
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013* 43
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2013* 44
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2013* 45
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Creighton University, 2013* 46
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2013* 47
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 48
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2013* 49
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts University, 2013* 50
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2013* 51
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2013* 52
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Winthrop-University Hospital, 2013* 53
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Medical Center, 2013* 54
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2013* 55
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Martin-Luther-Universitat Halle-Wittenberg, 2013* 56
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 57
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University, 2013* 58
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 59
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2013* 60
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2013* 61
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2013* 62
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2013* 63
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2013* 64
List of Figures
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 15
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
- Vitamin D Deficiency Disorders Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
- Vitamin D Deficiency Disorders Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
- Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
- Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
- GlobalData Methodology 86
See also Vitamin D Life
- Clinical Trials for Vitamin D - 2012
- Over 1000 Clinical Trials with Vitamin D INTERVENTION- Aug 2013
- Proof that Vitamin D Works which has the following summary
Vitamin D prevents or treats 94 health problems
ADHD, Alcoholic Liver Cirrhosis, ALS, Alzheimer's, Antibiotic Use in Seniors, Asthma, Autism, Autoimmune Diseases, Back pain, Blood Cell Cancer, Breast Cancer, Cardiovascular, Cholesterol, Chronic Hives, Chronic Kidney Disease, Cluster Headaches, Congestive Heart Failure (Infants), COPD, Crohn's Disease, C-Section and Pregnancy Risks, Cystic Fibrosis, Depression, Diabetes, Diabetic Neuropathy, Eczema, Falls, Fatigue, Fatty Liver (Child), Fibromyalgia, Gestational Diabetes, Gingivitis, Growing Pains, Hay Fever, Heart Attack, Hemodialysis, Hepatitis-C, Hip Fractures, Hypertension, Influenza, Irritable Bowel Syndrome, Ischemic Stroke, Knee Osteoarthritis, Leg Ulcers, Low Birth Weight, Lupus, Male Infertility, Menstrual Pain, Metabolic Syndrome, Middle Ear Infection (Infants), Mite Allergy, Multiple Sclerosis, Non-Alcoholic Fatty Liver Disease, Osteoarthritis, Parkinson's Disease, Perinatal Depression, Pneumonia (Ventilator-associated), Poor Sleep, PreDiabetes, Preeclampsia, Pre-term Birth, Prostate Cancer, Quality of Life, Raynaud's Pain, Respiratory Tract Infection, Restless Leg Syndrome, Rheumatoid Arthritis, Rickets, Sarcopenia, Sepsis, Short Neonates, Sickle Cell, Stronger Senior Muscles, Survive ICU, TB, Tonsillitis, Trauma Death, Traumatic Brain Injury, Tuberculosis, Ulcerative Colitis, Urinary Tract Infection, Vaginosis, Vertigo, Warts, Weight Loss
Reminder: Translate icon in the upper right selects a different language
Click on underlined items for details
| Health Problem | Treat Prevent | Reduction by Vit D | RCT = Randomized Controlled Trial * = link to additional RCT CT = Clinical Trial |
| Hypertension | T P | 149 to 142 mm Hg HT risk reduced 10X | RCT* *, 2400 IU. 100,000 IU* When Vitamin D > 40 ng |
| Cardiovascular after attack | T | 32 % fewer deaths | CT 1000 IU |
| Diabetes Type 1 | P | 85 % | 12,000 kids, 2000 IU |
| Diabetes Type 2 | T | 62 % | RCT* CRP reduction, 4000 IU Injection is far better - RCT * RCT 50,000 IU/2weeks + probiotics RCT 5,000 IU daily 6 months |
| Back Pain | T | 95 % reduced 50% | 5000/10000 IU 60,000 IU weekly |
| Influenza | P | 90 % | RCT *, 2000 IU |
| Falls | P | 50% | RCT, 100,000 IU monthly RCT with Meals on Wheels 2016 |
| Hip Fractures | P | 30 % | RCT * 800 IU |
| Rickets | P | 98 % | Turkey, 400 IU NOT RCT, given to all children |
| Raynaud's Syndrome | T | 40 % | RCT, visual scale, 20000 IU Avg |
| Menstrual pain | P | 76 % | RCT, 7000 IU Avg, 70% reduction 2018 PMS reduced by half |
| Pregnancy risks | P | 50 % | RCT, 4000 IU |
| C-section, unplanned | P | 50 % | RCT, 4000 IU, small study |
| Low birth weight | P | 60 % | RCT * 1000 IU of D2 |
| TB | P | 60 % | RCT, 800 IU |
| Breast Cancer | P | 60 % | RCT, 1100 IU (2007) |
| Rheumatoid Arthritis pain | T | 40 % | RCT, 500 IU, added to prescription |
| Cystic Fibrosis | T | 75 % 2nd study improved | RCT, pilot 4X fewer deaths 250,000 IU RCT, pilot 8,200 IU |
| Chronic Kidney | T | 90 to 70 PTH | RCT, 3500 IU, |
| Respiratory Tract Infection | P | 63 % | 3 RCT, 4000 IU 1 year 2nd 2000/800 IU 20,000 IU weekly |
| Lupus | T T | zero flares Pain reduced | Loading then 100,000 IU monthly, RCT too RCT 4,000 IU |
| Sickle Cell | T | Less pain | RCT, up to 100,000 IU/week |
| Leg ulcer healing | T | 4X faster | RCT, 50,0000 IU/week, small study |
| Traumatic Brain Injury | T | 2X | RCT, 20,0000 IU/day with progesterone |
| Parkinson's Disease | T | Stabilized | RCT, 1200 IU/day |
| Multiple Sclerosis | P T | 68% 95% were CURED | RCT, 7100 IU prevent pre-MS ==> MS 20,000 to 140,000 IU/day |
| Congestive Heart Failure | T | 90 % | RCT, 1000 IU infants (also: Adults, not RCT) |
| Middle Ear Infection | P | 30 % | RCT, 1000 IU infants |
| Gingivitis | T | 88 % | RCT, 2000 IU |
| Muscle in seniors | T | 17 % more muscle | RCT, 4000 IU |
| Antibiotic use when >70y | T | 47 % | RCT, 60,000 IU monthly |
| Infants taller | Benefit | 1 cm tall | RCT, 50,000 IU weekly, for 8 weeks while pregnant |
| Gestational Diabetes | T | Reduced 3X | RCT, 2 doses of 50,000 IU |
| After Heart Attack | T | +6% ejection fraction | RCT, 800,000 IU one time |
| Prostate Cancer | T | Fewer +cores | RCT, 4000 IU (2012) |
| Asthma | P T | Reduced symptoms | RCT, 60K IU/month; RCT 50K IU/week Need good D at 4 weeks into preg. |
| Depression | T | Reduced | RCT 300,000 IU injection RCT 1500 IU helped Prozac RCT 50,000 IU weekly, elderly |
| Low vitamin D while breastfed | P | All infants > 20 mg | RCT, 5,000 IU |
| Fibromyalgia | T | Half of many still has Fibro | RCT, 30-48 ng RCT 50K IU/week |
| Hives, Chronic | T | Reduced 40% | RCT, 4000 IU added |
| Cholesterol | T | Reduced 4 mg | RCT, 400 IU + Ca |
| Weight Loss | T | lost 5 more lbs | RCT, 2000 IU +diet +exercise |
| Gestational Diabetes | P | 40% | RCT * , 5,000 IU |
| Chronic Obstructive Pulmonary Disease | T | 17X improvement | CT, 50,000 IU weekly RCT 100,000 IU monthly |
| Asthma | T | 1/2 Asthma attacks | RCT >42 mg of vitamin D |
| Quality of Life (QoL) | T | Nursing Home QoL | CT, 4,000 IU in daily bread |
| Death of Critically Ill Patients | T | 20% increase in survivability | RCT 540 K IU loading than 90K monthly |
| Restless Leg Syndrome | T | Score 26 ==> 10 | CT, Vitamin D dose size not stated in abstract |
| Hepatitis-C | T | Aided normal drugs | RCT 2.000 IU |
| Crohn's disease | T | improved when > 30 ng 2nd study fewer relapses | RCT 2,000 IU 10,000 IU RCT |
| Pre-term birth | P | 2.5X decrease, also: fewer c-section & better Apgar | RCT 2,000 IU India |
| Cluster headaches | T | CH eliminated in 60% | 10,000 IU, Mg, Omega-3, etc |
| Autism | T | 80% improved | CT 300 IU/kg/day for 3 months |
| PreDiabetes | T | ~20% reduced | RCT 60,000 IU/month |
| Weight loss: Overweight and Obese | T | 12 lbs in 6 months | RCT 100,000 IU/month |
| Sarcopenia = muscle loss | T | 27% increase | RCT 1,000 IU |
| Growing Pains | T | 60% decrease | ~100,000 IU/month -NOT RCT 2nd study, similar results |
| Osteoarthritis pain | T | 60% decrease | 50,000 IU/weekly - NOT RCT |
| ALS | T | helped | 2,000 IU - NOT RCT, given to all |
| Vertigo | T | 3X reduction if raised > 10ng | 600,000 IU load, then maint. NOT RCT, given to all |
| Warts | T | 80% eliminated injection | NOT RCT 60,000 IU/injection |
| Metabolic Syndrome | P | reduced 44% when VitD increased by 30 ng | NOT RCT, given to all |
| Hay fever | P | reduced 48% | RCT 1,000 IU for 30 days |
| Preeclampsia | P | Recurrance cut in half 3 RCT 3.6 X less likely if > 30 ng | 50,000 IU every 2 weeks 4,000 IU daily |
| Blood cell cancer Multiple Myeloma | T | Survival 90% vs 50% | 10,000 IU/week NOT RCT, given to all |
| Irritable Bowel Syndrome | T | Reduced | 3,000 IU spray RCT |
| Urinary Tract Infection | P | 50% reduction | RCT 20,000 IU weekly |
| Mite Allergy | P | 5X reduction | RCT 2,000 IU preg, 800 IU child |
| Perinatal depression (depression near birth) | T | 50% reduction | RCT 2,000 IU for just a few weeks |
| Vaginosis | T | 10X reduction | RCT 2,000 IU |
| Eczema | T | Reduced | 2 RCT 1,600 IU |
| Non-Alcoholic Fatty Liver Disease | T | Reduced | RCT 20,000 IU weekly |
| Knee Osteoartiritis | T | Pain Reduced | RCT 60,000 IU monthly after loading dose |
| Tuberculosis | T | Faster Recovery | RCT single 450,000 IU dose |
| Stroke - Ischemic | T | Faster Recovery | RCT single 600,000 IU injection RCT single 300,000 IU injection |
| Sepsis | T | Reduce ICU and Hospital length of stay by 7 days each | RCT 400,000 IU |
| Trauma deaths | T | 50% fewer deaths | Vitamin D & Glutamine NOT RCT, given to all |
| Hemodialysis patients | T | helped | 50,000 IU weekly NOT RCT, given to all |
| Fatty liver - child | T | 2 X reduction | RCT Vitamin D & DHA |
| Fatigue | T | Reduced | 100,000 IU single dose NOT RCT, given to all |
| Sleep Disorders | T | Nicely treated | RCT 50.000 IU bi-weekly |
| Pneumonia (Ventilator-associated) | T | RCT Death rate cut in half | 300,000 IU injection |
| Infertile males | T | birth rate doubled | RCT 300,000 IU + maint |
| Waist size | T | Waist size reduced 3 cm | 100,000 IU loading + maint for 6 months for those with Metabolic Syndrome NOT RCT, given to all |
| Attention Deficient Hyperactivity Disorder | T | Reduced Reduced | RCT 3,000 IU for 12 weeks RCT 50,000 IU weekly |
| Alcoholic liver cirrhosis | T | improved survival | 1,000 IU of vitamin D NOT RCT |
| Diabetic nephropathy | T | Reduced HOMA-IR, FRS | RCT 50,000 IU weekly |
| Ulcerative Colitis | T | Reduced 60% | RCT 50,000 IU nano daily for a week |
| Obese weight loss | T | Lost 3X more pounds | $10 of Vitamin D added to calorie restriction & walking |
| Endometriosis | T | Nicely treated | RCT 50.000 IU bi-weekly |
| Diabetic Wounds | T | 4X more likely to heal | RCT 6,400 daily |
| Alzheimer's | T | Often reverse | Each person gets a different amount of Vit D, Omega-3, B12, Iron, etc |
| Autoimmune | P | Decrease 30% | RCT Vit D + Omega-3 |
| Smoking | T | reduce problems | RCT 50,000 bi-weekly |
| Tonsillitis | T | Virtually eliminated | RCT 50,000 weekly |